About Skylarr Labs
Skylarr Labs is a Healthcare company. Pharmaceutical manufacturing and marketing of quality formulations in India. The company has 1 employees. Its Indian entity Skylarr Labs Private Limited reported revenue of ₹13.96 Cr. Skylarr Labs offers products and services including Tablets and Capsules. Its focus areas include Biotechnology, Research and Development, Biosimilars and Pharmaceuticals.
Company details
Skylarr Labs is identified as a fast-growing pharmaceutical company that engages in the manufacturing and marketing of quality formulations, including tablets, capsules, liquids, dry syrups, ointments, and protein powders, all adhering to GMP standards and Schedule M compliance. Research efforts are directed towards areas such as cardio-metabolic diseases, oncology, and biosimilars to address healthcare needs. The company operates manufacturing units in India, Brazil, and the USA, with plans to market around 200 products through ethical channels and PCD franchises, emphasizing regulatory adherence and innovation in the pharmaceutical landscape.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook Instagram
- Legal Name Skylarr Labs Pvt Ltd
- Date of Incorporation 12 Apr, 2022
- Jurisdiction Pune, Maharashtra, India
- Indian entity revenue₹13.96 Cr
FY 2024 · +123% YoY
- Indian entity net profit₹6.7 Lakh
FY 2024 · 0% margin
- Indian entity EBITDA₹57.1 Lakh
FY 2024 · 4% margin
- Employee Count1
Associated legal entities of Skylarr Labs
Skylarr Labs operates through Skylarr Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Skylarr Labs Private Limited CIN U51909PN2022PTC210311 | Active | 12 Apr 2022 | Pune, Maharashtra | ₹14.0 Cr | 4 | View details |
Products & Services of Skylarr Labs
Skylarr Labs offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured and marketed as part of a wide range of formulations under stringent quality control measures.
Capsules are produced at world-class GMP standards and are included in the company's ethical product lineup.
Board of directors of Skylarr Labs Private Limited (Skylarr Labs)
Skylarr Labs Private Limited is the primary company behind Skylarr Labs. The board of Skylarr Labs Private Limited currently have 4 directors; the longest-serving is Bhagyawanti Bharatkumar Oswal, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhagyawanti Bharatkumar Oswal DIN 07273451 | Director | 12 Apr 2022 | 4 yrs 6 mo | Skylarr Labs Private Limited |
| Harshal Bharatkumar Oswal DIN 09031560 | Director | 12 Apr 2022 | 4 yrs 6 mo | Skylarr Labs Private Limited |
| Nikita Harshal Oswal DIN 09570129 | Director | 12 Apr 2022 | 4 yrs 6 mo | Skylarr Labs Private Limited |
| Bharatkumar Tarachand Oswal DIN 09570128 | Director | 12 Apr 2022 | 4 yrs 6 mo | Skylarr Labs Private Limited |
Financials of Skylarr Labs
Figures of Skylarr Labs Private Limited, the primary company behind Skylarr Labs, for FY 2024. Revenue was ₹13.96 Cr (+123% year on year). Net profit was ₹6.7 Lakh (0% margin). EBITDA was ₹57.1 Lakh (4% margin).
- ₹13.96 CrRevenue · FY 2024 · +123% YoY
- ₹6.7 LakhNet profit · 0% margin
- ₹57.1 LakhEBITDA · 4% margin
- ₹4 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Skylarr Labs Private Limited are on its company page.
Detailed financial statements for Skylarr Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Skylarr Labs
Skylarr Labs has 1 employees.
The primary company behind Skylarr Labs, Skylarr Labs Private Limited, reported revenue of ₹13.96 Cr for FY 2024, up 123% year on year.
Skylarr Labs is identified as a fast-growing pharmaceutical company that engages in the manufacturing and marketing of quality formulations, including tablets, capsules, liquids, dry syrups, ointments, and protein powders, all adhering to GMP standards and Schedule M compliance. Research efforts are directed towards areas such as cardio-metabolic diseases, oncology, and biosimilars to address healthcare needs. The company operates manufacturing units in India, Brazil, and the USA, with plans to market around 200 products through ethical channels and PCD franchises, emphasizing regulatory adherence and innovation in the pharmaceutical landscape.
Skylarr Labs offers Tablets and Capsules.
Skylarr Labs operates through Skylarr Labs Private Limited.
The legal entities of Skylarr Labs currently have 4 directors, including Bhagyawanti Bharatkumar Oswal, Harshal Bharatkumar Oswal, Nikita Harshal Oswal and others.